(Q37182278)

English

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer

scientific article published on 27 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Z M A Mohammed

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J J Going

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J Edwards

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

B Elsberger

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

D C McMillan

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

27 August 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

109

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1676-1684

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

The prognostic impact of anti-cancer immune response: a novel classification of cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Hallmarks of Cancer: The Next Generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

B-cell: a logical target for treatment of rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

6 September 2017

CD20: a regulator of cell-cycle progression of B lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

14 September 2017

Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

14 September 2017

The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

26 June 2018

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

26 June 2018

Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

3 September 2018

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

3 September 2018

Inflammation and prognosis in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

3 September 2018

Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777002

3 September 2018

Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and necrosis promote tumour growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2013.493

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37182278&oldid=2199986548"